Form 4: Director Scott Shuda Receives InfuSystem Stock Options
Director Equity Compensation Disclosure
Director Scott Shuda was granted 24,890 stock options in InfuSystem Holdings, Inc. as part of a standard equity compensation arrangement.
Summary
- Director Scott Shuda received a grant of 24,890 stock options for InfuSystem Holdings, Inc. (INFU) common stock.
- The options have an exercise price of $8.37 per share.
- The options are scheduled to vest on May 12, 2027, and expire on May 12, 2036.
- Following this transaction, Mr. Shuda maintains direct ownership of 94,000 shares and indirect ownership of 298,383 shares through investment entities.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation that does not signal a change in company strategy or financial health.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- None identified; this is a routine equity grant for a director.
Risks
- Market volatility affecting the value of the granted options.
- Potential dilution of existing shareholders upon the eventual exercise of these options.
Future Outlook
The filing does not provide forward-looking business guidance, as it is a disclosure of director equity compensation.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term oversight and strategic alignment within the healthcare services sector.
Comparison to Industry Standards
- The grant of stock options to non-executive directors is consistent with standard compensation practices for small-cap healthcare companies.
- The vesting period of one year is typical for director equity awards in the U.S. market.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of 24,890 stock options to Director Scott Shuda. | 05/12/2026 | Minimal; standard alignment of director incentives. |
Related Party Transactions
- Mr. Shuda serves as Managing Director of TSV Investment Partners, LLC and BlueLine Partners, LLC, which hold shares of the issuer.
Stakeholder Impact
- Shareholders may experience minor dilution if these options are exercised in the future.
Next Steps
- Vesting of the granted options on May 12, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/12/2026 | Date of the option grant transaction. |
| 05/12/2027 | Vesting date for the granted stock options. |
| 05/12/2036 | Expiration date for the granted stock options. |
Keywords
InfuSystem, INFU, Form 4, Director Compensation, Stock Options, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.